Progress in Lipid Research
ISSN 0163-7827 · Elsevier BV · United Kingdom · active 1978–2026
Metrics
- Scimago quartile (2025)
- Q1
- Cites per paper (2y)
- 15.5
- SJR
- 4.786
- h-index
- 222
“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric (how the two differ). Citation rates differ enormously between fields, so compare within a discipline. What the other figures mean: journal quartile, SJR, h-index and article processing charge.
Data as of 18 October 2026 (venue index build).
Scimago Journal Rank 2025
In the Scimago Journal Rank 2025 edition, Progress in Lipid Research is Q1 in all 2 of its subject categories.
| Subject category | Quartile | Rank in category |
|---|---|---|
| Biochemistry | Q1 | #11 of 449 |
| Cell Biology | Q1 | #22 of 297 |
- Cites per document (2 years, Scopus)
- 20.00
- Documents indexed in 2025 (Scopus)
- 21
The quartile is the one Scimago prints for each category. Rank is the journal's position by SJR among the journals Scimago lists in that category (#1 is the highest); “—” means we hold no rank consistent with that quartile. The document count is what Scopus indexed that year, which can be lower than a journal's full output. Source: SCImago Journal Rank 2025 edition, from Scopus data (scimagojr.com, CC BY-NC).
Progress in Lipid Research is Q1 in all 2 of its Scimago subject categories (2025 edition; best category Biochemistry: Q1, #11 of 449), with SJR 4.786 (Scimago) and an h-index of 222 (OpenAlex). Listed in Scopus, Web of Science, PubMed.
Is this the right journal for your paper?
The AI Journal Finder ranks the best-matched journals for your paper’s topic — with tier, open access, citation rate and predatory flags. Free to start.
Indexing & access
- Indexed in
- ScopusWeb of SciencePubMed
- Access status:
- hybrid. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.
Scope
Frequently asked
Is Progress in Lipid Research a predatory journal?
Our screening does not flag Progress in Lipid Research. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in Scopus, Web of Science, PubMed, which is a positive signal.
Is Progress in Lipid Research indexed in Scopus or Web of Science?
Per our venue index, Progress in Lipid Research appears in: Scopus, Web of Science, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.
What is the impact factor of Progress in Lipid Research?
Papers in Progress in Lipid Research are cited about 15.5 times each within two years of publication, and Scimago places it in Q1, with an h-index of 222. Those are the open equivalents: the Clarivate Journal Impact Factor is a proprietary metric we neither compute nor license, so we show the two-year citation rate and Scimago quartile instead — they answer the same question of how heavily the journal is cited. A citation rate is a property of a field as much as of a journal.
What Scimago quartile is Progress in Lipid Research (Q1, Q2, Q3, or Q4)?
In the Scimago Journal Rank 2025 edition, Progress in Lipid Research is Q1 in all 2 of its subject categories. By category: Biochemistry: Q1, #11 of 449; Cell Biology: Q1, #22 of 297. Quartiles split the journals in a subject category into four equal groups by SJR, so Q1 is the most-cited quarter and Q4 the least; Progress in Lipid Research is cited about 15.5 times per paper over two years, with an h-index of 222.
What is the Web of Science (JCR) quartile of Progress in Lipid Research?
The Web of Science quartile comes from Clarivate's Journal Citation Reports (JCR), a proprietary product we neither license nor compute — so we cannot state a JCR quartile for Progress in Lipid Research. The open equivalent is its Scimago quartile, Q1, derived from Scopus citation data. Because JCR ranks against Web of Science and Scimago against Scopus, the two can differ, so check Clarivate's site directly if you need the JCR quartile specifically.
Is Progress in Lipid Research open access?
Our index records its access status as "hybrid". Where this is derived from publisher-level signals rather than works-level data it is a heuristic, so confirm on the journal's own site — particularly if an article processing charge matters to you.
Ready to submit? Tools for your next paper
Similar venues
- Drug Resistance UpdatesQ1 · Elsevier BV
- Advanced Drug Delivery ReviewsQ1 · Elsevier BV
- Cell Host & MicrobeQ1 · Cell Press
- Biomarker ResearchQ1 · BioMed Central
- World Journal of Microbiology and BiotechnologyQ1 · Springer Science+Business Media
- Acta Crystallographica Section F Structural Biology CommunicationsQ3 · Wiley
Compare it with its peers: Ranked Molecular Biology journals — ranked by Scimago quartile and cites per paper, predatory venues excluded.